GlassScriptPhysician profile
Vito Valentino
NPI 1578889705
$20,549.82
in general payments reported to CMS, 2019-2025
21 companies · $5,912 in 2025
The $5,912 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,689 · 2022: $2,123 · 2023: $3,872 · 2024: $6,954 · 2025: $5,912.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Travel and Lodging: $955.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,782.33 |
| Travel and Lodging | $955.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,170.42 | 2021-2025 | Azure Xt Dr Mri Surescan, Linq II, Micra |
| Boston Scientific Corporation | $3,640.44 | 2021-2025 | Watchman Flx, Emblem Mri S-Icd, Lux-Dx Insertable Cardiac Monitor |
| Abbott Laboratories | $3,617.33 | 2021-2025 | Aveir, Gallant, Ensite |
| Biosense Webster, INC. | $992.46 | 2021-2025 | Carto 3, Nuvision Ice Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $450.38 | 2021-2025 | Lifevest |
| Edwards Lifesciences Corporation | $374.61 | 2023-2024 | Hemosphere |
| Biotronik INC. | $229.44 | 2021-2025 | Amvia Edge, Acticor 7 Vr-T Dx, Pamira |
| Cardiva Medical, INC. | $186.48 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade 6/7f Vcs |
| Sanofi-Aventis U.S. LLC | $169.82 | 2021-2022 | |
| Pfizer INC. | $158.64 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $98.02 | 2022-2025 | Camzyos, Eliquis |
| Cordis US Corp. | $97.63 | 2025 | Mynx Control Venous |
| Csl Behring | $78.82 | 2024 | Kcentra, Haegarda |
| Atricure, INC. | $75.52 | 2023-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Janssen Pharmaceuticals, INC | $57.43 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $49.74 | 2024 | Assure Wcd |
| Itamar Medical INC | $34.48 | 2022-2025 | Watchpatone |
| Becton, Dickinson and Company | $21.00 | 2024 | Arista Ah Flexitip |
| Chiesi USA, INC. | $20.99 | 2024 | Kengreal |
| Novartis Pharmaceuticals Corporation | $19.73 | 2023 | |
| Elutia, INC. | $6.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vito Valentino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.